Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction of Muscle Catabolism Through Brain Activation in Burn Patients (REMBRANT)

NCT07435402 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT07435402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07435402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction of Muscle Catabolism Through Brain Activation in Burn Patients (REMBRANT)
Lead sponsor
Charles University, Czech Republic
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
June 30, 2030
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burns - multiple, critical illness, muscle weakness